Percutaneous Coronary Intervention Enhances Accelerative Wave Intensity in Coronary Arteries

Om Narayan1, Michael C H Leung1, Dennis T L Wong1

  • 1Monash Cardiovascular Research Centre, MonashHeart and School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia.

Plos One
|December 15, 2015
PubMed

Insights

Coronary stenosis reduces the intensity of key blood flow waves. Restoring flow with stenting significantly increases wave intensity, particularly in severe blockages, highlighting microvascular decompression

Area of Science:

  • Cardiovascular Physiology
  • Hemodynamics
  • Interventional Cardiology

Background:

  • Systolic forward traveling compression waves (sFCW) and diastolic backward traveling decompression waves (dBEW) are primary drivers of coronary blood flow.
  • The impact of coronary stenosis on these wave intensities in distal vessels was previously unknown.

Purpose of the Study:

  • To investigate the relationship between coronary stenosis severity and the intensity of sFCW and dBEW.
  • To assess the changes in wave intensity after percutaneous coronary intervention (PCI).

Main Methods:

  • Simultaneous intracoronary pressure and velocity measurements were taken during hyperemia in 17 patients.
  • Coronary Wave Intensity analysis (CWIA) was performed, alongside calculations of Fractional Flow Reserve (FFR) and Coronary Flow Velocity Reserve (CFVR).

Main Results:

  • dBEW intensity strongly correlated with FFR (R = -0.70) and CFVR (R = -0.73).
  • sFCW intensity also correlated with FFR (R = 0.71) and CFVR (R = 0.59).
  • PCI significantly increased sFCW (median 178%) and dBEW (median 117%) intensity, with larger increases seen in lesions with greater flow limitation.

Conclusions:

  • Reduced intensity of accelerative coronary waves correlates with increased ischemia severity.
  • Impaired diastolic microvascular decompression may be a key mechanism reducing coronary blood flow in epicardial stenosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
446
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
709
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
421
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
554